TickerFactsScreenerDevelopers

Ernexa Therapeutics Inc. (ERNA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: $2.83M2011: $574.0K2012: $2.16M2015: -$4.18M2016: $23.0K2017: $549.0K2018: $1.36M2019: $2.74M2020: -$8.10M2021: -$23.49M2022: -$20.98M2023: -$20.41M2024: -$15.84M2025: -$7.02M-$7.02M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.02M+55.7%
2024-$15.84M+22.4%
2023-$20.41M+2.7%
2022-$20.98M+10.7%
2021-$23.49M-189.9%
2020-$8.10M-395.2%
2019$2.74M+101.0%
2018$1.36M+148.6%
2017$549.0K+2287.0%
2016$23.0K+100.6%
2015-$4.18M—
2012$2.16M+275.6%
2011$574.0K-79.7%
2010$2.83M—